IgE, blood eosinophils and FeNO are not enough for choosing a monoclonal therapy among the approved options in patients with type 2 severe asthma

Type-2 inflammation is the most frequent endophenotype of asthma. Different biomarkers have been proposed to identify this inflammation because highly effective therapies have improved type-2 severe asthma control. We investigated the frequency of some biomarkers of type-2 inflammation (total IgE, s...

Descripción completa

Detalles Bibliográficos
Autores principales: Sánchez, Jorge, Morales, Edison, Santamaria, Luis-Carlos, Acevedo, Ana-Milena, Calle, Ana, Olivares, Margarita, Gomez, Carolina, Amaya, Daniel, Cardona, Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941083/
https://www.ncbi.nlm.nih.gov/pubmed/33747341
http://dx.doi.org/10.1016/j.waojou.2021.100520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941083/
https://www.ncbi.nlm.nih.gov/pubmed/33747341
http://dx.doi.org/10.1016/j.waojou.2021.100520

Ejemplares similares